Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis

Affiliations

¹ Department of Gastroenterology, University of California - Davis, Sacramento, CA, USA.
² Department of Medicine, University of Miami, Miami, FL, USA.

Editorial

Christopher L Bowlus et al. Aliment Pharmacol Ther. 2020 Jan.

. 2020 Jan;51(1):177-178.

doi: 10.1111/apt.15576.

¹ Department of Gastroenterology, University of California - Davis, Sacramento, CA, USA.
² Department of Medicine, University of Miami, Miami, FL, USA.

No abstract available

Comment on

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response.
Murillo Perez CF, Hirschfield GM, Corpechot C, Floreani A, Mayo MJ, van der Meer A, Ponsioen CY, Lammers WJ, Parés A, Invernizzi P, Carbone M, Maria Battezzati P, Nevens F, Kowdley KV, Thorburn D, Mason AL, Trivedi PJ, Lindor KD, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Janssen HLA, Hansen BE, Gulamhusein A; GLOBAL PBC Study Group. Murillo Perez CF, et al. Aliment Pharmacol Ther. 2019 Nov;50(10):1127-1136. doi: 10.1111/apt.15533. Epub 2019 Oct 17. Aliment Pharmacol Ther. 2019. PMID: 31621931

1. Corpechot C, Abenavoli L, Rabahi N, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48:871-877.
1. Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105:2186-2194.
1. Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology. 2006;130:715-720.
1. Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Therapy. Gastroenterology. 2015;149:1804-1812 e1804.
1. Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cirrhosis. Hepatology. 2016;63:930-950.